BUSINESS● LOWJul 20 · Jul 20, 2026, 2:12 AM
Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal
CNBC
South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowWhy Ecobank's opening to the yuan changes the game for the continentJeune AfriqueBUSINESS7m agoHong Kong bus operators seek fare hikes of up to 17.7% amid fuel price surgeSouth China Morning Post